Consumption of green tea alters glial fibriliary acidic protein immunoreactivity in the spinal cord astrocytes of STZ-diabetic rats

Nutritional Neuroscience

Volumn 11, Issue 1, 2008, Pages 32-40

  Renno, Waleed M ^a   Alkhalaf, Moussa ^a   Afsari, Zainab ^a   Abd El Basset, Ebtesam ^a   Mousa, Alyaa ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Antioxidation; GFAP; Green tea; Rat; Spinal cord; STZ

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN TEA EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL COUNT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; STREPTOZOCIN DIABETES;

ANIMALS; ASTROCYTES; CELL COUNT; DIABETES MELLITUS, EXPERIMENTAL; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; MALE; PHYTOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; TEA;

RATTUS;

EID: 45749107518     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/147683008X301405     Document Type: Article

References (60)

1. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH. Cerebral function in diabetes mellitus. Diabetologia 1994, 37: 643-650.
2. Gispen WH, Biessels GJ. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000; 23: 542-549.
3. Ichikawa F, Yamada K, Ishiyama-Shigemoto S, Yuan X, Nonaka K. Association of an (A-C)n dinucleotide repeat polymorphic marker at the 5′-region of the aldose reductase gene with retinopathy but not with nephropathy or neuropathy in Japanese patients with Type 2 diabetes mellitus. Diabet Med 1999; 16: 744-748.
4. Greene DA, Stevens MJ, Obrosova I, Feldman EL. Glucose induced oxidative stress and programmed cell death in diabetic neuropathy. Eur J Pharmacol 1999; 30: 217-223.
5. Zaltzberg H, Kanter Y, Aviram M, Levy Y. Increased plasma oxidizability and decreased erythrocyte and plasma antioxidative capacity in patients with NIDDM. Isr Med Assoc J 1999; 1: 228-231.
6. Hawkins CL, Davies MJ. Generation and propagation of radical reactions on proteins. Biochim Biophys Acta 2001; 1504: 196-219.
7. Kaneko K, Nakamura A, Yoshida K, Kametani F, Higuchi K, Ikeda S. Glial fibrillary acidic protein is greatly modified by oxidative stress in aceruloplasminemia brain. Free Radic Res 2002; 36: 303-306.
8. Barber AJ, Antonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. Invest Ophthalmol Vis Sci 2000; 41: 3561-3568.
9. Montgomery DL. Astrocytes: form, functions, and roles in disease. Vet Pathol 1994; 31: 145-167.
10. Lamigeon C, Bellier JP, Sacchettoni S, Rujano M, Jacquemont B. Enhanced neuronal protection from oxidative stress by coculture with glutamic acid decarboxylase-expressing astrocytes. J Neurochem 2001; 77: 598-606.
11. Norton WT, Aquino DA Hozumi I, Chiu FC, Brosnan CF. Quantitative aspects of reactive gliosis. Neurochem Res 1992; 17: 877-885.
12. Reier PJ, Houle JD. The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. Adv Neurol 1988; 47: 138-187.
13. Liedtke W, Edelmann W, Bieri PL et al. GFAP is necessary for the integrity of CNX white matter architecture and long-term maintenance of myelination. Neuron 1996; 17: 607-615.
14. Saravia FE, Revsin Y, Gonzalez Deniselle MC et al. Increased astrocyte reactivity in the hippocampus of murine models of type 1 diabetes: the nonobese diabetic (NOD) and streptozotocin-treated mice. Brain Res 2002; 957: 345-353.
15. Baydas G, Nedzvetskii VS, Tuzcu M, Yasar A, Kirichenko SV. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur J Pharmacol 2003; 462: 67-71.
16. Rungger-Brandle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 2000; 41: 1971-1980.
17. Magistretti PJ, Pellerin L. Astrocytes couple synaptic activity to glucose utilization in the brain. News Physiol Sci 1999; 14: 177-182.
18. Chan DK, Woo J, Ho SC. Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry 1998; 65: 781-784.
19. Mandel SA, Avramovich-Tirosh Y, Reznichenko L et al. Multifactorial activities of green tea catechins in neuroprotection. Neurosignals 2005; 14: 46-60.
20. Levites Y, Weinreb O, Maor G, Youdim MB, Mandel S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,-3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J Neurochem 2001; 78: 1073-1082.
21. Nie G, Jin C, Cao Y, Shen S, Zhao B. Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. Arch Biochem Biophys 2002; 397: 84-97.
22. Levites Y, Youdim MB, Maor G, Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-AB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 2002; 63: 21-29.
23. Wu LY, Juan CC, Hwang LS, Hsu YP, Ho LT. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr 2004; 43: 116-124.
24. Dulloo AG, Duret C, Rohrer D et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 1999; 70: 1040-1045.
25. Tsuneki H, Ishizuka M, Terasawa M, Wu JB, Sasaoka T, Kimura I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol 2004; 4: 18-28.
26. Anderson RA, Polansky MM. Tea enhances insulin activity. J. Agric Food Chem 2002; 50: 7182-7186.
27. Wu LY, Juan CC, Ho LT, Hsu YP, Hwang LS. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J Agric Food Chem 2004; 52: 643-648.
28. Rakieten N, Rakieten ML, Moreshwar VN. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Report 1963; 29: 91-98.
29. Renno WM, Saleh F, Klepacek I, Al-Awadi F. Talin immunogold density increases in sciatic nerve of diabetic rats after nerve growth factor treatment. Medicina (Kaunas) 2006; 42: 147-163.
30. Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature 1997; 387: 561.
31. Renno WM, Saleh F, Klepacek I, Al-Khaledi G, Ismael H, Asfar S. Green tea pain modulating effect in sciatic nerve chronic constriction injury rat model. Nutr Neurosci 2006; 9: 41-47.
32. Abd-El-Basset EM, Kalnins VI, Ahmed I, Fedoroff S. A 48 kiloDalton intermediate filament associated protein (IFAP) in reactive-like astrocytes induced by dibutyryl cyclic AMP in culture and in reactive astrocytes in situ. J Neuropathol Exp Neurol 1989; 48: 245-254.
33. Baydas G, Retter RJ, Yaser A, Tuzcu M, Akdemir I, Nedzvetskii V. Melatonin reduces glial reactivity in the hippocampus, cortex and cerebellum of streptozotocin-diabetic rats. Free Radic Biol Med 2003; 35: 797-804.
34. Coleman E, Judd R, Hoe L, Dennis J, Posner P. Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 2004; 48: 166-178.
35. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 2003; 52: 506-511.
36. Goodison KL, Parhad IM, White 3rd CL, Sima AA, Clark AW. Neuronal and glial gene expression in neocortex of Down's syndrome and Alzheimer's disease. J Neuropathol Exp Neurol 1993; 52: 192-198.
37. McCall MA, Gregg RG, Behringer RR et al. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc Natl Acad Sci USA 1996; 93: 6361-6366.
38. Kakinuma Y, Hama H, Sugiyama F et al. Impaired blood-brain barrier function in angiotensinogen-deficient mice. Nat Med 1998; 4: 1078-1080.
39. Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 2002; 200: 629-638.
40. Stuesse SL, Crisp T, McBurney DL, Schechter JB, Lovell JA, Cruce WL. Neuropathic pain in aged rats: behavioral responses and astrocytic activation. Exp Brain Res 2001; 137: 219-227.
41. Louw DF, Masada T, Sutherland GR. Ischemic neuronal injury is ameliorated by astrocyte activation. Can J Neurol Sci 1998; 25: 102-107.
42. Abu El-Asrar AM, Meersschaert A, Dralands L, Missotten L, Geboes K. Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes. Eye 2004; 18: 306-313.
43. Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes 1998; 47: 445-449.
44. Tanihara H, Hangai M, Sawaguchi S et al. Up-regulation of glial fibrillary acidic protein in the retina of primate eyes with experimental glaucoma. Arch Ophthalmol 1997; 115: 752-756.
45. Lieth E, Barber AJ, Xu B et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 1998; 47: 815-820.
46. Hermengildo C, Raya A, Roma J, Romero, FJ. Decreased glutathione peroxidase activity in sciatic nerve of alloxan-induced diabetic mice and its correlation with blood glucose levels. Neurochem Res 1993, 18: 893-896.
47. Van Dam PS, Varr Asbeck S, Bravenboer B, Van Oirschot JFLM, Marx JJM, Gispen WH. Nerve conduction and antioxidant levels in experimentally diabetic rats: effects of streptozotocin dose and diabetes duration. Metabolism 1999; 48: 442-447.
48. Nagamatsue, M, Nickander KK, Schmelzer JD et al. Lipoic acid improves nerve blood flow, reduces, oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995; 18: 1160-1167.
49. Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 1989; 14: 175-185.
50. Mandel S, Youdim M. Flavonoids and isoflavones (phytoestrogens): absorption, metabolism and bioactivity. Free Radic Biol Med 2004; 37: 304-317.
51. Yokozawa T, Nakagawa T, Kitani K. Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J Agric Food Chem 2002; 50: 3549-3552.
52. Skrzydlewska E, Ostrowska J, Farbiszewski R, Michalak K. Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine 2002; 9: 232-238.
53. Negishi H, Xu JW, Ikeda K, Njelekela M, Nara Y, Yamori Y. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr 2004; 134: 38-42.
54. Kaneko T, Matsuo M, Baba N. Inhibition of linoleic acid hydroperoxide-induced toxicity in cultured human umbilical vein endothelial cells by catechins. Chem Biol Interact 1998; 114: 109-119.
55. de Groot H, Rauen U. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol 1998; 12: 249-255.
56. Fiala ES, Sodum RS, Bhattacharya M, Li H. (-)-Epigallocatechin gallate, a polyphenolic tea antioxidant, inhibits peroxynitrite-mediated formation of 8-oxodeoxyguanosine and 3-nitrotyrosine. Experientia 1996; 15: 922-926.
57. Kashima M. Effects of catechins on superoxide and hydroxyl radical. Chem Pharm Bull (Tokyo) 1999; 47: 279-283.
58. Sabu MC, Smitha K, Kuttan R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes J Ethnopharm 2002; 83: 109-116.
59. Sutherland BA, Rahman RMA, Appleton I. Mechanism of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J Nutr Biochem 2006; 17: 291-306.
60. Wolfram S, Raederstorff D, Preller M et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 2006; 136: 2512-2518.